JP2022548312A5 - - Google Patents

Info

Publication number
JP2022548312A5
JP2022548312A5 JP2022518190A JP2022518190A JP2022548312A5 JP 2022548312 A5 JP2022548312 A5 JP 2022548312A5 JP 2022518190 A JP2022518190 A JP 2022518190A JP 2022518190 A JP2022518190 A JP 2022518190A JP 2022548312 A5 JP2022548312 A5 JP 2022548312A5
Authority
JP
Japan
Prior art keywords
glycero
alkyl
compound according
phosphocholine
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022518190A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548312A (ja
JP7642620B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/051629 external-priority patent/WO2021055849A1/en
Publication of JP2022548312A publication Critical patent/JP2022548312A/ja
Publication of JP2022548312A5 publication Critical patent/JP2022548312A5/ja
Application granted granted Critical
Publication of JP7642620B2 publication Critical patent/JP7642620B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022518190A 2019-09-19 2020-09-18 治療剤の細胞内送達のための頭部基脂質化合物及び組成物 Active JP7642620B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962902928P 2019-09-19 2019-09-19
US62/902,928 2019-09-19
PCT/US2020/051629 WO2021055849A1 (en) 2019-09-19 2020-09-18 Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents

Publications (3)

Publication Number Publication Date
JP2022548312A JP2022548312A (ja) 2022-11-17
JP2022548312A5 true JP2022548312A5 (OSRAM) 2023-09-26
JP7642620B2 JP7642620B2 (ja) 2025-03-10

Family

ID=72840615

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022518190A Active JP7642620B2 (ja) 2019-09-19 2020-09-18 治療剤の細胞内送達のための頭部基脂質化合物及び組成物

Country Status (11)

Country Link
US (1) US20230000773A1 (OSRAM)
EP (1) EP4031527A1 (OSRAM)
JP (1) JP7642620B2 (OSRAM)
KR (1) KR20220103923A (OSRAM)
CN (1) CN114746398A (OSRAM)
AU (1) AU2020351225A1 (OSRAM)
BR (1) BR112022004771A2 (OSRAM)
CA (1) CA3154720A1 (OSRAM)
IL (1) IL291375A (OSRAM)
MX (1) MX2022003402A (OSRAM)
WO (1) WO2021055849A1 (OSRAM)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS63030B1 (sr) 2015-09-17 2022-04-29 Modernatx Inc Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava
JP7114465B2 (ja) 2015-12-22 2022-08-08 モデルナティエックス インコーポレイテッド 薬剤の細胞内送達のための化合物および組成物
US11583504B2 (en) 2016-11-08 2023-02-21 Modernatx, Inc. Stabilized formulations of lipid nanoparticles
CN110167587A (zh) 2016-11-11 2019-08-23 摩登纳特斯有限公司 流感疫苗
CA3056133A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Crystal forms of amino lipids
KR20190132405A (ko) 2017-03-15 2019-11-27 모더나티엑스, 인크. 치료제의 세포내 전달을 위한 화합물 및 조성물
ES3020935T3 (en) 2017-03-15 2025-05-23 Modernatx Inc Lipid nanoparticle formulation
US12077501B2 (en) 2017-06-14 2024-09-03 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
KR20210018323A (ko) 2018-06-06 2021-02-17 매사추세츠 인스티튜트 오브 테크놀로지 진핵 세포에서의 번역을 위한 원형 rna
AU2019345067A1 (en) 2018-09-19 2021-04-08 Modernatx, Inc. High-purity peg lipids and uses thereof
WO2020061367A1 (en) 2018-09-19 2020-03-26 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
KR20210133218A (ko) 2019-01-31 2021-11-05 모더나티엑스, 인크. 볼텍스 믹서 및 연계된 방법, 시스템 및 이의 장치
CN113874502A (zh) 2019-03-11 2021-12-31 摩登纳特斯有限公司 补料分批体外转录方法
JP7686574B2 (ja) 2019-05-22 2025-06-02 マサチューセッツ インスティテュート オブ テクノロジー 環状rna組成物及び方法
CA3155015A1 (en) 2019-09-19 2021-03-25 Modernatx, Inc. Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
MX2022003269A (es) 2019-09-19 2022-07-04 Modernatx Inc Compuestos lipidicos de cola ramificada y composiciones para la administracion intracelular de agentes terapeuticos.
AU2020397956A1 (en) 2019-12-04 2022-07-07 Orna Therapeutics, Inc. Circular RNA compositions and methods
CA3200234A1 (en) 2020-11-25 2022-06-02 Daryl C. Drummond Lipid nanoparticles for delivery of nucleic acids, and related methods of use
AU2022245247A1 (en) * 2021-03-24 2023-10-05 Modernatx, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
JP2024515964A (ja) * 2021-04-26 2024-04-11 オハイオ ステート イノベーション ファウンデーション 脂質ナノ材料及びその使用
US20220363937A1 (en) 2021-05-14 2022-11-17 Armstrong World Industries, Inc. Stabilization of antimicrobial coatings
CN114149337B (zh) * 2021-07-07 2022-04-29 天津键凯科技有限公司 一种用于核酸递送的新型可电离脂质及其lnp组合物
WO2023018773A1 (en) * 2021-08-11 2023-02-16 Modernatx, Inc. Lipid nanoparticle formulations and methods of synthesis thereof
CN113461577B (zh) * 2021-09-01 2021-12-14 中山大学附属第七医院(深圳) 一种氨基脂质及其应用
IL309505A (en) 2021-09-03 2024-02-01 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
US20250027108A1 (en) 2021-10-29 2025-01-23 CureVac SE Improved circular rna for expressing therapeutic proteins
AR127892A1 (es) 2021-12-10 2024-03-06 Modernatx Inc Compuestos y composiciones para la administración de agentes terapéuticos
US20250099614A1 (en) 2022-01-28 2025-03-27 CureVac SE Nucleic acid encoded transcription factor inhibitors
WO2023154818A1 (en) 2022-02-09 2023-08-17 Modernatx, Inc. Mucosal administration methods and formulations
CN116813493B (zh) * 2022-03-21 2026-04-28 苏州科锐迈德生物医药科技有限公司 一种脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂
KR102560772B1 (ko) * 2022-03-21 2023-07-28 주식회사 메디치바이오 신규한 이온화지질 및 이를 이용한 지질나노입자 조성물
EP4509544A4 (en) * 2022-04-12 2025-07-02 Xiamen Sinopeg Biotech Co Ltd NONLINEAR PEGYLATED LIPID CONTAINING TERTIARY AMINE AND ITS APPLICATION
CA3248209A1 (en) 2022-05-25 2023-11-30 CureVac SE Escherichia coli Antigenic Polypeptide-Based Nucleic Acid Vaccine (FIMH)
EP4531819A2 (en) 2022-05-25 2025-04-09 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
US12297285B2 (en) 2022-06-24 2025-05-13 Orna Therapeutics, Inc. Circular RNA encoding chimeric antigen receptors targeting BCMA
CN115232128B (zh) * 2022-08-15 2024-03-29 中国科学技术大学 一种咪唑并吡啶基脂质化合物及其制备方法与应用
CN115557875B (zh) * 2022-08-19 2025-01-03 上海耐澄生物科技有限公司 一种脂质化合物及脂质纳米颗粒
EP4608442A1 (en) 2022-10-28 2025-09-03 GlaxoSmithKline Biologicals S.A. Nucleic acid based vaccine
EP4627085A1 (en) * 2022-11-29 2025-10-08 The Trustees of Indiana University Long non-coding rna lipter preserves lipid metabolism of the human heart
EP4630397A1 (en) 2022-12-08 2025-10-15 ModernaTX, Inc. Ionizable lipids with malonate tails
WO2024140835A1 (zh) * 2022-12-28 2024-07-04 仁景(苏州)生物科技有限公司 脂质化合物和脂质纳米颗粒组合物
CN115677518B (zh) * 2023-01-05 2023-04-14 北京悦康科创医药科技股份有限公司 用于递送核酸的可电离阳离子脂质化合物和组合物及用途
CN118356505A (zh) * 2023-01-10 2024-07-19 复旦大学 含末端羟基的peg化纳米载体在制备规避人体预存抗peg抗体的药物制剂中的用途
EP4665736A2 (en) * 2023-02-13 2025-12-24 Flagship Pioneering Innovations VII, LLC Cleavable linker-containing ionizable lipids and lipid carriers for therapeutic compositions
JP2026509258A (ja) 2023-03-08 2026-03-17 キュアバック エスイー 核酸送達のための新規な脂質ナノ粒子製剤
WO2024197310A1 (en) 2023-03-23 2024-09-26 Modernatx, Inc. Peg targeting compounds for delivery of therapeutics
EP4683665A1 (en) 2023-03-23 2026-01-28 ModernaTX, Inc. Peg targeting compounds for delivery of therapeutics
EP4683666A1 (en) 2023-03-23 2026-01-28 ModernaTX, Inc. Peg targeting compounds for delivery of therapeutics
EP4721759A1 (en) 2023-04-29 2026-04-08 Cansino (Shanghai) Biological Research Co., Ltd. Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof
JP2026513706A (ja) 2023-04-29 2026-04-30 カンシノ (シャンハイ) バイオロジカル リサーチ カンパニー リミテッド ステロイド-カチオン性脂質化合物およびその応用
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases
CN116675624B (zh) * 2023-05-29 2025-02-14 上海耐澄生物科技有限公司 一种脂质化合物及脂质纳米颗粒
KR20240172540A (ko) * 2023-06-01 2024-12-10 주식회사 기프티드엠에스 세포 투과가 가능한 펩타이드-핵산 올리고머를 유효성분으로 포함하는 코로나바이러스 감염 질환 예방 또는 치료용 약학적 조성물
WO2024259373A1 (en) 2023-06-14 2024-12-19 Modernatx, Inc. Compounds and compositions for delivery of therapeutic agents
WO2025100737A1 (ko) * 2023-11-06 2025-05-15 주식회사 메디치바이오 신규한 이온화 지질 및 이를 포함하는 지질 나노입자 조성물
CN119798203A (zh) * 2024-01-05 2025-04-11 仁景(苏州)生物科技有限公司 用于递送的脂质化合物和脂质纳米颗粒
CN117942406B (zh) * 2024-01-19 2025-07-11 晟迪生物医药(苏州)有限公司 预制载体在制备用于免疫细胞和干细胞的体外基因递送的产品中的应用
CN118290339B (zh) * 2024-03-20 2025-03-07 北京剂泰医药科技有限公司 可电离脂质化合物及其应用
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026035680A1 (en) 2024-08-06 2026-02-12 Kernal Biologics, Inc. Compositions and methods for delivery of agents
US20260098014A1 (en) * 2024-10-08 2026-04-09 Flagship Pioneering Innovations Vii, Llc Ionizable lipidoid compositions and therapeutic uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2817287T3 (da) * 2012-02-24 2019-01-02 Arbutus Biopharma Corp Trialkyl kationisk lipid og metoder til anvendelse deraf
WO2015011633A1 (en) * 2013-07-23 2015-01-29 Protiva Biotherapeutics, Inc. Compositions and methods for delivering messenger rna
SI3350333T1 (sl) 2015-09-17 2022-04-29 ModernaTX,Inc. Polinukleotidi, ki zajemajo stabilizacijsko repno regijo
RS63030B1 (sr) 2015-09-17 2022-04-29 Modernatx Inc Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava
EP3359670B2 (en) 2015-10-05 2024-02-14 ModernaTX, Inc. Methods for therapeutic administration of messenger ribonucleic acid drugs
KR20190132405A (ko) * 2017-03-15 2019-11-27 모더나티엑스, 인크. 치료제의 세포내 전달을 위한 화합물 및 조성물
EP3735270A1 (en) * 2018-01-05 2020-11-11 Modernatx, Inc. Polynucleotides encoding anti-chikungunya virus antibodies
US20190314291A1 (en) * 2018-01-30 2019-10-17 Modernatx, Inc. Compositions and methods for delivery of agents to immune cells
WO2020061367A1 (en) * 2018-09-19 2020-03-26 Modernatx, Inc. Compounds and compositions for intracellular delivery of therapeutic agents

Similar Documents

Publication Publication Date Title
JP2022549253A5 (OSRAM)
JP2022548304A5 (OSRAM)
JP2025502627A5 (OSRAM)
JP6442551B2 (ja) 薬物送達用の脂質ナノ粒子の生成方法
JP5977394B2 (ja) 脂質に封入された干渉rna
EP3239132B1 (en) Cationic lipid
JP2022501360A5 (OSRAM)
JP2020532528A5 (OSRAM)
JP2020514366A5 (OSRAM)
JP6389477B2 (ja) カチオン性脂質
JP7423518B2 (ja) 生物学的活性分子を送達するための融合性化合物
WO2011056682A1 (en) Reverse head group lipids, lipid particle compositions comprising reverse headgroup lipids, and methods for the delivery of nucleic acids
US20190380963A1 (en) Liposome preparation having high-content cationic lipid compound and use thereof
AU2013380825B2 (en) Lipidosome preparation, preparation method and application thereof
IL319522A (en) Ionizable lipid materials, nanoparticles containing them, and their uses
CN115417779B (zh) 可离子化的阳离子脂c6-a1及由其组成的纳米脂质体颗粒
CN115417780B (zh) 可离子化的阳离子脂c5-a2及由其组成的纳米脂质体颗粒
JP5914418B2 (ja) 脂質粒子、核酸送達キャリア、核酸送達キャリア製造用組成物、脂質粒子の製造方法及び遺伝子導入方法
CN119365189A (zh) 一种高转染效率的阳离子脂质纳米粒及其制备方法
WO2025256540A1 (en) Compositions and method for targeted gene delivery
KR20260059895A (ko) 신규한 이온화 스테롤 유도체 및 이를 포함하는 지질 나노입자 조성물
CN120774809A (zh) 一种肺靶向脂质纳米颗粒的构建及应用
CN119019272A (zh) 可电离脂质、包含其的组合物及其用途
CN120040464A (zh) 一种新型可电离脂质分子的制备和应用
CN119896747A (zh) 一种负载降低转甲状腺素蛋白核酸的含钙脂质纳米粒